Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells

Area of Science:

• Molecular Biology
• Cancer Research
• Hepatology

Background:

• Transforming growth factor-beta (TGF-β) signaling is crucial for cell growth control.
• Resistance to TGF-β's growth inhibitory effects is common in cancers, but mechanisms are unclear.
• Understanding these mechanisms is vital for developing targeted cancer therapies.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying resistance to TGF-β-induced growth repression in cancer.
• To identify novel regulatory pathways involving microRNAs and signaling molecules in hepatocytes.
• To investigate the role of histone deacetylase 1 (HDAC1) in hepatocellular carcinoma progression.

Main Methods:

• Investigated the interaction between TGF-β signaling, Smad proteins, and microRNA-195 (miR-195) in hepatocytes.
• Utilized molecular biology techniques to analyze gene expression, protein interactions, and promoter activity.
• Employed cell culture models of normal hepatocytes and hepatoma cells, including gene silencing experiments.

Main Results:

• Identified a positive feedback loop in normal hepatocytes where TGF-β signaling activates miR-195 transcription, which in turn enhances TGF-β signaling.
• Demonstrated that HDAC1 overexpression in hepatoma cells represses miR-195 transcription, disrupting this feedback loop.
• Showed that HDAC1-mediated repression of miR-195 contributes to resistance against TGF-β-induced growth inhibition in liver cancer cells.

Conclusions:

• HDAC1-induced down-regulation of miR-195 is a key mechanism for cancer cells to evade TGF-β-mediated growth suppression.
• The TGF-β-Smad2/3-miR-195-Smad7 circuitry plays a critical role in preventing uncontrolled cell proliferation.
• Targeting HDAC1 or restoring miR-195 levels may represent a therapeutic strategy for hepatocellular carcinoma.